Circulation, Vol 71, 602-609, Copyright © 1985 by American Heart Association
T Force, AJ Kemper, C Cohen and AF Parisi
Studies in animals with acutely ischemic hearts have suggested that
postextrasystolic potentiation (PESP) may predict the viability of
dysfunctional myocardium. Most of these data have been obtained with
sonomicrometers and therefore the presence and extent of PESP throughout
the entire region at risk has not been defined. In this study we used
contrast two-dimensional echocardiography (2DE) to define region at risk in
vivo, and then with quantitative 2DE we examined the proportion of the
region at risk that demonstrated PESP, the degree of the potentiation, and
the time course of this response. The region at risk was divided into a
central (inner 50%) and two peripheral (25% each) ischemic zones. Adjacent
contrast-enhanced myocardium was divided into near and far border zones
that were equal in size to the adjacent peripheral ischemic zone. Systolic
thickening was analyzed within each zone along multiple radii at 5, 30, and
120 min after coronary occlusion. PESP was absent in the central ischemic
zone at all three times. In the peripheral ischemic zone at 5 min, a small
amount of PESP was detected (-4.1% vs + 3.1% for nonpotentiated and
potentiated thickening, respectively; p less than .01). At 30 min after
occlusion, no potentiation was seen in the region at risk and PESP was
confined to the contrast-enhanced near and far border zones. These findings
persisted at 120 min. These data indicate that the response to PESP is
localized to perfused myocardium by 30 min after acute occlusion. PESP is
therefore of limited value in predicting the presence of ischemic,
potentially viable myocardium early in the course of acute infarction.
ARTICLES
Early loss of postextrasystolic potentiation in acutely ischemic myocardium: evaluation by contrast two-dimensional echocardiography
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |